If you Google the words 'Harbin Pharmaceutical Plant', you will find photos of a palatial interior. The facility has marble floors, paintings and chandeliers.
This is a listed company, with a market capitalisation of about US$2 billion, and investors might ask why the plant is so extravagantly decorated.
There is no easy answer to that question. But the firm may provide an insight into why the mainland economy is slowing. After decades of stellar growth and a massive state stimulus in 2008-09, China is showing signs of waste, of which marble flooring in a pharmaceutical plant is just the beginning.
I bring this up because there is a large, lean market that shows little of this excess. Its profit levels are high, its workforce is motivated and, because it has been something of a basket case for the past five years, its equities are out of favour and cheap. I refer to the United States.
We have become as accustomed to hearing bad news about the US as we have good news about emerging markets. But in my opinion the American economy is slowly and quietly on the mend.
We can see this from consumer confidence statistics to purchasing managers indices (which measure business confidence).